mRNA vaccine access carves up world into haves and have-nots
Adding to the list of inequities that the pandemic has only worsened, nations are freshly divided on the lines of access to mRNA vaccines. Developed and rich nations have stocked up billions of vaccine doses developed employing the revolutionary messenger RNA technology, that are proving more and more effective in preventing infections and serious disease caused by virulent and deadly variants. However, the US and and handful of European nations have access to these doses, while the rest the world is in a desperate race to catch up. From South